EUVIMEDEUVIMED entdecken
Open Access

TREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathwayTREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway

Xudong Jiu, Wenjie Li, Yang Liu, Lin Liu, Hong Lu

International Journal of Molecular Medicine · 2024

DOI: 10.3892/ijmm.2024.5420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2024. Verfasst von Xudong Jiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, P.R. China. Hauptthemen laut MEDLINE: Pyroptosis, Uveal Neoplasms, Stilbenes, Melanoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uveal melanoma (UM) is the most prevalent type of primary intraocular malignancy and is prone to metastasize, particularly to the liver. However, due to the poor understanding of the pathogenesis of UM, effective therapeutic approaches are lacking. As a phenolic compound extracted from grapes, piceatannol (PIC) exhibits anti‑cancer properties. To the best of our knowledge, however, the effects of PIC on UM have not been well investigated. Therefore, in the present study, considering the impact of pyroptosis on modulating cell viability, the mechanism underlying the effects of PIC on UM cell proliferation was explored. The inhibitory effect of PIC on proliferation of UM cells was detected by cell counting kit‑8 assay. Wound healing was used to investigate the effects of PIC on the migration of UM cells. Activity detecting assays were performed to test the apoptosis and oxidant level in UM cells. Western blotting and RT‑qPCR were used to detect the inflammatory and pyroptotic levels of UM cell after PIC treatment. PIC‑treated UM cells were screened by high‑throughput sequencing to detect the differential expression of RNA and differential genes. Si‑TREM2 transfection was used to verify the important role of TREM2 in the effects of PIC. Immunohistochemical staining was used to observe the expressions of TREM2 and GSDMR of tumor in nude mice after PIC administration. PIC effectively inhibited proliferation ability of C918 and Mum‑2b UM cell lines via enhancing apoptosis, as evidenced by enhanced activities of caspase 3 and caspase 9. In addition, treatment of UM cells with PIC attenuated cell migration in a dose‑dependent manner. PIC increased reactive oxygen species levels and suppressed the activity of the antioxidant enzymes superoxide dismutase, glutathione‑S‑transferase, glutathione peroxidase and catalase. PIC inhibited inflammatory responses in C918 cells. PIC treatment upregulated IL‑1β, IL‑18 and Nod‑like receptor protein 3 and downregulated gasdermin D (GSDMD). RNA sequencing results revealed the activation of an unconventional pyroptosis‑associated signaling pathway, namely caspase 3/GSDME signaling, following PIC treatment, which was mediated by triggering receptor expressed on myeloid cells 2 (TREM2) upregulation. As an agonist of TREM2, COG1410‑mediated TREM2 upregulation inhibited proliferation of C918 cells, displaying similar effects to PIC. Furthermore, PIC inhibited tumor growth via regulating the TREM2/caspase 3/GSDME pathway in a mouse model. Collectively, the present study revealed a novel mechanism underlying the inhibitory effects of PIC on UM, providing a potential treatment approach for UM in clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisUveal NeoplasmsStilbenesMelanomaCaspase 3Receptors, ImmunologicAnimalsMiceCell Line, TumorHumansCell ProliferationSignal TransductionAntineoplastic AgentsCell MovementMice, NudeMembrane GlycoproteinsUveal Melanoma

Stichwörter der Autor:innen

inflam-mationoxidative stresspiceatannolpyroptosistriggering receptor expressed on myeloid cells 2uveal melanoma

Substanzen

3,3',4,5'-tetrahydroxystilbeneStilbenesCaspase 3Receptors, ImmunologicAntineoplastic AgentsTREM2 protein, humanMembrane Glycoproteins

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
  • Department of Ophthalmology, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China.

Zitieren

APA

Jiu, X., Li, W., Liu, Y., Liu, L., & Lu, H. (2024). TREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathwayTREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2024.5420

Vancouver

Jiu X, Li W, Liu Y, Liu L, Lu H. TREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathwayTREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway. International Journal of Molecular Medicine. 2024. doi:10.3892/ijmm.2024.5420

BibTeX
@article{Jiu2024,
  author = {Jiu, Xudong and Li, Wenjie and Liu, Yang and Liu, Lin and Lu, Hong},
  title = {TREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathwayTREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway},
  journal = {International Journal of Molecular Medicine},
  year = {2024},
  doi = {10.3892/ijmm.2024.5420}
}
Kostenlos starten →